21st WRIB Highlights

Full Immersion in Bioanalysis
  • Small & Large Molecules
  • Biomarkers
  • Immunogenicity
  • Gene/Cell Therapy
  • Vaccine Assays
  • Critical Reagents
  • Peptide & Oligos
  • New Modalities
  • LBA, Flow Cytometry
  • PCR, ELISpot, NGS
  • LC-MS/MS & HRMS
  • Hybrid LBA/LCMS
  • Emerging Technologies
Hear from Regulators...
  • US FDA
  • EU EMA
  • UK MHRA
  • Health Canada
  • Brazil ANVISA
  • Austria AGES
  • Belgium FAMHP
  • Italy AIFA
Learn What's New...
  • Method Dev. Challenges
  • Novel Case Studies
  • Emerging Approaches
  • Regulatory Standards
3-DAY Main Workshop
  • No Overlap Parallel Sessions
  • Flexibility to Choose Main Workshop DAYs
7 full-day Specialized Workshops
  • Spread throughout the week
  • Each with an in-depth Focus to maximize your learning process
Personalized Agenda
  • Choose your Main Workshop DAYs
  • Then Combine with Specialized Workshops of your interest
Questions to Regulators
  • Ask them directly to regulators at WRIB
  • Or Submit yours questions before WRIB if you want to be anonymous
Complete Speakers Slides
  • Distributed BEFORE meeting
Poster Awards
  • Free Registration for Next WRIB
  • Interviewed by Bioanalysis Journal
  • Appear in a speical feature report in the Bioanalysis Journal and on Bioanalysis Zone

21st WRIB Poster Abstract Submission is now OPEN

Submission Deadline: February 05, 2027

Participate with a Poster in this international forum to present your advanced research to the global bioanalytical community, share your knowledge and expertise and have open discussions with other colleagues on your cutting-edge research that can have an impact on the Drug Discovery and Development.

Poster Acceptance Criteria:

  • Please ensure to highlight the Novelty of your Research in the submitted abstracts vs. already published/presented material (abstracts already presented at other conferences will NOT be accepted);
  • Abstracts must be actual data-driven & Non-Commercial;
  • Abstracts will be accepted based on 1) Novelty, 2) Relevance, and 3) Quality of your Data/Research.

Each attendee is permitted to present only ONE poster, and there is no restriction of the number of co-authorships.

Abstracts must have minimum 300 words (longer abstracts are welcome!) in total including title, novel aspect, introduction, method, results and conclusion.

All the posters will be presented during one of the Main Workshop DAYs based on the topic of your poster to match the Main Workshop program.

The size of poster boards is 8'X4' (8 feet wide and 4 feet high).

AGAIN Poster Award: There will be poster contest at the 21st WRIB like in previous years, and presenters of 3-4 most outstanding posters (one from each Day) will each recieve free registration for next WRIB Main Workshop, as well as an interview by Bioanalysis Journal team, and appearing in a speical feature report in the Bioanalysis Journal and on Bioanalysis Zone.



20th WRIB Poster Award Winners

WRIB is proud to announce that each year WRIB Poster Screening Committee follows extremely high standard in strictly selecting the best Posters based on 1) Novelty 2) Relevance and 3) Quality of Data/Research with a high rejection rate of over 50% of submitted abstracts.

Hence, as expected, the quality of the posters presented at the 20th WRIB was so high that the Award Committee took a while to score & select the winning ones.

Finally here is the list of 20th WRIB's poster award winners (in order of Poster Numbers):

  • Day1-P01: Category ADA

    "A streamlined ADA testing strategy to assess the clinical immunogenicity of a biological drug entering clinical development"
    - Séverine Sarlang, argenx

  • Day1-P15: Category BAV, LBA

    "Development and Validation of a High-Performance Soluble BCMA Ligand-Binding Assay to Support Biomarker Evaluation in Multiple Myeloma Clinical Studies at Moderna"
    - Yingwen Xiao, Moderna Therapeutics Inc.

  • Day2-P01: Category GCV

    "Development and validation of a clinical nAb assay for a replicating oncolytic virus"
    - Gurleen Saini, Boehringer Ingelheim Pharmaceuticals, Inc.

  • Day2-P10: Category MDx

    "An Innovative Strategy for a Unified High‑Throughput Direct‑to‑qPCR Workflow for Oligonucleotides Quantitation in Tissue and Plasma Without Nucleic Acid Extraction"
    - Swati Dass, Resolian

  • Day2-P16: Category CBA

    "Applying Quantitative Imaging Flow Cytometry with Cytek® Amnis® in Early Development of Biotherapeutic Modalities"
    - Zhiheng He, Pfizer

  • Day3-P08: Category MSA, BAV

    "Method Development and Validation for the Determination of Two Protein Biomarkers by Multiplexed Online and Offline Hybrid LC-MS/MS in Human Heart Tissue"
    - Taylor Dufield, KCAS Bio

Each Poster Award Winner receives a free registration for 21st WRIB Main Workshop in Chicago, as well as an interview by Bioanalysis Journal team, and appearing in a speical feature article in the Bioanalysis Journal and on Bioanalysis Zone.


Previous Years Poster Award Winners